Skip to main content

Aperiodic Neural Activity is a Better Predictor of Schizophrenia than Neural Oscillations

July 10, 2023
Diagnosis and symptom severity in schizophrenia are associated with irregularities across neural oscillatory frequency bands, including theta, alpha, beta, and gamma. However, electroencephalographic signals consist of both periodic and aperiodic activity characterized by the (1/fX) shape in the power spectrum. In this paper, we investigated oscillatory and aperiodic activity differences...

Associations of alcohol and cannabis use with change in posttraumatic stress disorder and depression symptoms over time in recently trauma-exposed individuals

July 10, 2023
In this study involving recent trauma-exposed civilians, researchers aimed to understand the complex relationship between substance use, posttraumatic stress disorder (PTSD), and depression. They utilized a large multisite dataset and tracked alcohol and cannabis use trajectories as well as PTSD and depression symptoms over a span of 3 months. The...

Anxiety Screening: Evidence Report and Systematic Review for the US Preventive Services Task Force.

July 10, 2023
Evidence was insufficient to draw conclusions about the benefits or harms of anxiety screening programs. However, clear evidence exists that treatment for anxiety is beneficial, and more limited evidence indicates that some anxiety screening instruments have acceptable accuracy to detect generalized anxiety disorder.

Depression and Suicide Risk Screening: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

July 10, 2023

Aperiodic Neural Activity is a Better Predictor of Schizophrenia than Neural Oscillations

July 10, 2023
EEG signals consist of both periodic and aperiodic activity, characterized by the (1/fX) shape in the power spectrum but the utility of this activity has not been examined in a task between schizophrenia patients and healthy control participants. We discovered that the steepness of the power spectrum better-predicted group status...

Striatal dopamine in anhedonia: A simultaneous [11C]raclopride positron emission tomography and functional magnetic resonance imaging investigation

July 10, 2023
This study used to simultaneous PET-MR to detect reduced striatal dopamine functioning during reward processing and blunted mesocorticolimbic network functional connectivity in a transdiagnostic sample with clinically significant anhedonia.  

Dr. Robyn Jordan shares advocacy for telehealth at meeting with U.S. Senator Tillis in Raleigh with a mental health care agenda

July 10, 2023

Dr. Michael Baca-Atlas contributes to NBC News article on xylazine in the illegal drug supply

July 7, 2023

Dr. Nate Sowa tells Spectrum News 1, there’s been a surge in demand for behavioral health care and services, using technology such as telehealth allows existing providers to reach more patients than they did previously, especially in rural areas.

July 5, 2023

Patrick Sullivan, MD, FRANZCP and the Psychiatric Genomic Consortium have produced a new packet for the journal Science, to give researchers another way to understand human disease, using the power of evolutionary genomics.

June 30, 2023